Immunosuppression alters disease severity in juvenile Batten disease mice

Journal of Neuroimmunology

Volumn 230, Issue 1-2, 2011, Pages 169-172

  Seehafer, Sabrina S ^a   Ramirez Montealegre, Denia ^a   Wong, Andrew MS ^b   Chan, Chun Hung ^a   Castaneda, Julian ^a   Horak, Michael ^b   Ahmadi, Sarah M ^b   Lim, Ming J ^b   Cooper, Jonathan D ^b   Pearce, David A ^a,c  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Batten disease; CLN3; Immunosuppression; JNCL

Indexed keywords

AUTOANTIBODY; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN G; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBELLUM NUCLEUS; CONTROLLED STUDY; DISEASE SEVERITY; GENICULATE NUCLEUS; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; MOTOR PERFORMANCE; MOUSE; NERVE DEGENERATION; NEURONAL CEROID LIPOFUSCINOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; ROTAROD TEST; TASK PERFORMANCE;

ANIMALS; AUTOANTIBODIES; BLOTTING, WESTERN; BRAIN; CELL COUNT; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR CHAPERONES; MOTOR SKILLS; MYCOPHENOLIC ACID; NEURONAL CEROID-LIPOFUSCINOSES; NEURONS;

EID: 78650993597     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.08.024     Document Type: Article

References (16)

1. Bible E., Gupta P., Hofmann S.L., Cooper J.D. Regional and cellular neuropathology in the palmitoyl protein thioesterase-1 null mutant mouse model of infantile neuronal ceroid lipofuscinosis. Neurobiol. Dis. 2004, 16:346-359.
2. Castaneda J.A., Pearce D.A. Identification of alpha-fetoprotein as an autoantigen in juvenile Batten disease. Neurobiol. Dis. 2008, 29:92-102.
3. Chattopadhyay S., Ito M., Cooper J.D., Brooks A.I., Curran T.M., Powers J.M., Pearce D.A. An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease. Hum. Mol. Genet. 2002, 11:1421-1431.
4. Chattopadhyay S., Kriscenski-Perry E., Wenger D.A., Pearce D.A. An autoantibody to GAD65 in sera of patients with juvenile neuronal ceroid lipofuscinoses. Neurology 2002, 59:1816-1817.
5. Goebel H.H., Wisniewski K.E. Current state of clinical and morphological features in human NCL. Brain Pathol. 2004, 14:61-69.
6. Gundersen H.J., Jensen E.B. The efficiency of systematic sampling in stereology and its prediction. J. Microsc. 1987, 147:229-263.
7. Kitamura D., Roes J., Kuhn R., Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 1991, 350:423-426.
8. Kovacs A.D., Pearce D.A. Attenuation of AMPA receptor activity improves motor skills in a mouse model of juvenile Batten disease. Exp. Neurol. 2008, 209:288-291.
9. Lim M.J., Beake J., Bible E., Curran T.M., Ramirez-Montealegre D., Pearce D.A., Cooper J.D. Distinct patterns of serum immunoreactivity as evidence for multiple brain-directed autoantibodies in juvenile neuronal ceroid lipofuscinosis. Neuropathol. Appl. Neurobiol. 2006, 32:469-482.
10. Lim M.J., Alexander N., Benedict J.W., Chattopadhyay S., Shemilt S.J., Guerin C.J., Cooper J.D., Pearce D.A. IgG entry and deposition are components of the neuroimmune response in Batten disease. Neurobiol. Dis. 2007, 25:239-251.
11. Mitchison H.M., Bernard D.J., Greene N.D., Cooper J.D., Junaid M.A., Pullarkat R.K., de Vos N., Breuning M.H., Owens J.W., Mobley W.C., Gardiner R.M., Lake B.D., Taschner P.E., Nussbaum R.L. Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]. Neurobiol. Dis. 1999, 6:321-334.
12. Mole S.E. The genetic spectrum of human neuronal ceroid-lipofuscinoses. Brain Pathol. 2004, 14:70-76.
13. Ramirez-Montealegre D., Chattopadhyay S., Curran T.M., Wasserfall C., Pritchard L., Schatz D., Petitto J., Hopkins D., She J.X., Rothberg P.G., Atkinson M., Pearce D.A. Autoimmunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease. Neurology 2005, 64:743-745.
14. Siintola E., Lehesjoki A.E., Mole S.E. Molecular genetics of the NCLs - status and perspectives. Biochim. Biophys. Acta 2006, 1762:857-864.
15. Weimer J.M., Custer A.W., Benedict J.W., Alexander N.A., Kingsley E., Federoff H.J., Cooper J.D., Pearce D.A. Visual deficits in a mouse model of Batten disease are the result of optic nerve degeneration and loss of dorsal lateral geniculate thalamic neurons. Neurobiol. Dis. 2006, 22:284-293.
16. Weimer J.M., Benedict J.W., Getty A.L., Pontikis C.C., Lim M.J., Cooper J.D., Pearce D.A. Cerebellar defects in a mouse model of juvenile neuronal ceroid lipofuscinosis. Brain Res. 2009, 1266:93-107.